AB
OMIC

Amalgamated Bank’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Amalgamated Bank’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-194
Closed -$7K – 3157
2023
Q1 		$7K Sell
194
-41
-17% -$2.51K ﹤0.01% 2868
2022
Q4 		$14K Hold
235
– – ﹤0.01% 2831
2022
Q3 		$18K Hold
235
– – ﹤0.01% 2845
2022
Q2 		$27K Buy
235
+107
+84% +$12.5K ﹤0.01% 2773
2022
Q1 		$24K Buy
+128
New +$29.6K ﹤0.01% 2749

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amalgamated Bank's OMIC Position: Q2 2023 in Review

Amalgamated Bank sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 194 shares — an estimated $7K sold.

Amalgamated Bank first reported a position in OMIC in Q1 2022 and held it in 5 quarters. The position peaked at $27K in Q2 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • Amalgamated Bank reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 194 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $7K.
  • Amalgamated Bank first reported a position in Singular Genomics Systems, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Singular Genomics Systems, Inc. Common Stock position peaked at $27K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.